Vector Space Biosciences: Leading Innovation in Space Medicine with AI
Read Now!
Online
Log in
Explore
Drug Knowledgebase
Start here! Dig into essential drug information
Advanced Exploration
Categories & ATC Classifications
Pathways
Drug Reactions
Drug Classification
Drug Targets
Advanced Search
Target Sequence
Spectra Search
Pharmaco-omics
Chemical Structure
Data Library
Academic Downloads
Interaction Checker
Get More
Navigate to
DrugBank.com
to check out our commercial products, use cases and more!
DrugBank For Clinical Software
Clinical API
Clinical intelligence tool for your software
Features
Drug Search
Customizable drug search options
Drug-Drug Interaction Checker
Search for drug interactions with our API
Drug Allergy
Get drug allergy and cross sensitivities info
US Drug Labels
Integrate drug manufacturer information
Log in
Drugs
Targets
Pathways
Indications
Drugs
Drugs
Targets
Pathways
Indications
Log in or create an account for full access to this data.
Create Account
Log in
Refractory Cancer
Also known as:
Cancer Refractory
Drug Trials
Drug
Drug Name
Drug Description
Drug
Drug Name
Target
Type
Drug
Drug Name
Phase
Status
Count
DB01262
Decitabine
0
Active Not Recruiting
1
DB09037
Pembrolizumab
0
Active Not Recruiting
1
DB06021
AV-412
1
Completed
1
DB11945
Avelumab
1
Completed
1
DB15254
Avutometinib
1
Recruiting
1
DB01101
Capecitabine
1
Recruiting
1
DB14917
Ceralasertib
1
Completed
1
DB00531
Cyclophosphamide
1
Active Not Recruiting
1
DB16047
Elraglusib
1
Active Not Recruiting
1
DB00762
Irinotecan
1
Active Not Recruiting
1
DB09035
Nivolumab
1
Recruiting
1
DB01229
Paclitaxel
1
Completed
1
DB09037
Pembrolizumab
1
Completed
1
DB09037
Pembrolizumab
1
Recruiting
3
DB06240
Tariquidar
1
Completed
1
DB00853
Temozolomide
1
Active Not Recruiting
1
DB01030
Topotecan
1
Active Not Recruiting
1
DB14707
Cemiplimab
1 / 2
Recruiting
2
DB00531
Cyclophosphamide
1 / 2
Not Yet Recruiting
1
DB11714
Durvalumab
1 / 2
Completed
1
DB13874
Enasidenib
1 / 2
Terminated
1
DB01073
Fludarabine
1 / 2
Not Yet Recruiting
1
DB09053
Ibrutinib
1 / 2
Recruiting
1
DB00762
Irinotecan
1 / 2
Not Yet Recruiting
1
DB13982
Lutetium Lu-177
1 / 2
Recruiting
1
DB15186
Paxalisib
1 / 2
Not Yet Recruiting
1
DB09037
Pembrolizumab
1 / 2
Recruiting
1
DB15069
Pexastimogene devacirepvec
1 / 2
Completed
1
DB14904
Pimasertib
1 / 2
Not Yet Recruiting
1
DB00073
Rituximab
1 / 2
Recruiting
1
DB17370
TBX-3400
1 / 2
Recruiting
1
DB00853
Temozolomide
1 / 2
Not Yet Recruiting
1
DB11771
Tremelimumab
1 / 2
Completed
1
DB11581
Venetoclax
1 / 2
Terminated
1
DB08916
Afatinib
2
Terminated
1
DB00062
Albumin human
2
Active Not Recruiting
1
DB01169
Arsenic trioxide
2
Recruiting
1
DB06769
Bendamustine
2
Recruiting
1
DB06769
Bendamustine
2
Unknown Status
1
DB00112
Bevacizumab
2
Recruiting
1
DB00958
Carboplatin
2
Active Not Recruiting
1
DB00997
Doxorubicin
2
Active Not Recruiting
1
DB16047
Elraglusib
2
Active Not Recruiting
1
DB16672
Epcoritamab
2
Recruiting
1
DB00441
Gemcitabine
2
Active Not Recruiting
1
DB01611
Hydroxychloroquine
2
Recruiting
1
DB09053
Ibrutinib
2
Unknown Status
1
DB00762
Irinotecan
2
Active Not Recruiting
1
DB01097
Leflunomide
2
Recruiting
1
DB01206
Lomustine
2
Active Not Recruiting
1
DB14123
Menthol
2
Active Not Recruiting
1
DB00338
Omeprazole
2
Recruiting
1
DB01229
Paclitaxel
2
Active Not Recruiting
1
DB09037
Pembrolizumab
2
Recruiting
1
DB00642
Pemetrexed
2
Recruiting
1
DB00073
Rituximab
2
Unknown Status
1
DB14765
Rivoceranib
2
Unknown Status
1
DB15035
Zanubrutinib
2
Recruiting
1
DB16655
Teclistamab
4
Not Yet Recruiting
1
DB06273
Tocilizumab
4
Not Yet Recruiting
1